Guardant Health, Inc. (GH): debt financing — Guardant Health issues $600M 1.25% convertible notes due 2031; retires $659.3M of 0% notes due 2027

Guardant Health, Inc.

Exchanged $600M new 1.25% convertible notes due 2031 for $659.3M of existing 0% notes due 2027.
After close, $490.7M of 2027 notes remain outstanding; new notes mature Feb 15, 2031.
Initial conversion price ~$62.22/share (35% premium to Feb 6 closing price).
Up to 13,017,960 shares may be issued upon conversion based on initial max conversion rate.
New notes are senior unsecured; interest payable semi-annually at 1.25%.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

Guardant Health, Inc. incurred convertible notes of $600 million aggregate principal amount at 1.25% per annum maturing February 15, 2031.

Instrument: convertible notes
Principal: $600 million aggregate principal amount
Rate: 1.25% per annum
Maturity: February 15, 2031
Event: incurrence

Exact text from the filing

issued $600 million aggregate principal amount of 1.25% Convertible Senior Notes due 2031

View on SEC.gov

10 debt financings filed in the last 30 days. Browse all debt financings →

Guardant Health, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-25-027362

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.